U
MLAB icon

UBS’s Mesa Laboratories MLAB Stock Holding History

UBS’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$99K Buy
1,715
+733
+75% +$53.2K ﹤0.01% 6010
2014
Q2 		$82K Sell
982
-860
-47% -$71.1K ﹤0.01% 6193
2014
Q1 		$166K Buy
1,842
+880
+91% +$74.8K ﹤0.01% 5411
2013
Q4 		$75K Buy
962
+462
+92% +$33.7K ﹤0.01% 6416
2013
Q3 		$34K Hold
500
– – ﹤0.01% 7361
2013
Q2 		$27K Buy
+500
New +$25.9K ﹤0.01% 7512

Other funds holding MLAB

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

UBS's MLAB Position: Q3 2014 in Review

UBS increased its Mesa Laboratories (MLAB) stake by 75% in Q3 2014, buying an estimated $53.2K and bringing the position to 1,715 shares worth $99K. The position accounts for ﹤0.01% of the portfolio, ranked #6010.

UBS first reported a position in MLAB in Q2 2013 and has held it in 6 quarters since. The position peaked at $166K in Q1 2014. 58 funds tracked by Wall St. Rank hold MLAB as of Q3 2014.

  • UBS held 1,715 shares of Mesa Laboratories worth $99K as of Q3 2014.
  • UBS bought 733 Mesa Laboratories shares in Q3 2014, an estimated $53.2K.
  • Mesa Laboratories made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6010 holding.
  • UBS first reported a position in Mesa Laboratories in Q2 2013 and has held it in 6 quarters since.
  • UBS's Mesa Laboratories position peaked at $166K in Q1 2014.
  • 58 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.